Scientists from St. Jude Children’s Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerability in a set of difficult-to-treat childhood leukemias. Read more: https://www.stjude.org/media-resources/news-releases/2026-medicine-science-news/targeting-rbm5-may-help-disrupt-undruggable-myc-in-childhood-leukemia.html